10 Einträge von 16 mit Kate Niazi
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Julie Kim | Bill Mezzanotte | Melinda Gates | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine How you can help: Donate plasma
Kombination Keywords plasma nouvelles | covid leader | behring donate | alliance this | covig have | from maladie | trial site | patients plus | nous berne | notre savoir |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering serious health cons Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering seri
Text Inhalt Text aus URL
Log Metriken 636246
erkannte Namen Julie Kim | Bill Mezzanotte | Melinda Gates | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine How you can help: Donate plasma
Kombination Keywords plasma nouvelles | covid leader | behring donate | alliance this | covig have | from maladie | trial site | patients plus | nous berne | notre savoir |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering serious health cons Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering seri
Text Inhalt Text aus URL
Log Metriken 636246
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Julie Kim | Bill Mezzanotte | Melinda Gates | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine How you can help: Donate plasma
Kombination Keywords plasma find | behring location | covid have | alliance news | from this | covig serious | trial that | more people | learn with | patients health |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering serious health cons Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering seri
Text Inhalt Text aus URL
Log Metriken 446053
erkannte Namen Julie Kim | Bill Mezzanotte | Melinda Gates | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine How you can help: Donate plasma
Kombination Keywords plasma find | behring location | covid have | alliance news | from this | covig serious | trial that | more people | learn with | patients health |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering serious health cons Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering seri
Text Inhalt Text aus URL
Log Metriken 446053
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Julie Kim | Bill Mezzanotte | Melinda Gates | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine How you can help: Donate plasma
Kombination Keywords plasma find | behring location | covid news | alliance this | covig have | from serious | trial that | more with | learn people | patients health |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering serious health cons Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering seri
Text Inhalt Text aus URL
Log Metriken 446053
erkannte Namen Julie Kim | Bill Mezzanotte | Melinda Gates | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine How you can help: Donate plasma
Kombination Keywords plasma find | behring location | covid news | alliance this | covig have | from serious | trial that | more with | learn people | patients health |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering serious health cons Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering seri
Text Inhalt Text aus URL
Log Metriken 446053
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Julie Kim | Bill Mezzanotte | Melinda Gates | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine How you can help: Donate plasma
Kombination Keywords plasma disease | behring that | covid media | alliance location | from health | covig people | trial this | patients have | more serious | learn with |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering serious health cons Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering seri
Text Inhalt Text aus URL
Log Metriken 446053
erkannte Namen Julie Kim | Bill Mezzanotte | Melinda Gates | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine How you can help: Donate plasma
Kombination Keywords plasma disease | behring that | covid media | alliance location | from health | covig people | trial this | patients have | more serious | learn with |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering serious health cons Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering seri
Text Inhalt Text aus URL
Log Metriken 446053
www.cslbehring.ch
Datum der Indexierung
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine How you can help: Donate plasma
Kombination Keywords plasma donate | behring help | covid that | alliance location | covig have | from health | trial people | patients this | more serious | learn with |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering serious health cons Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering seri
Text Inhalt Text aus URL
Log Metriken 446053
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine How you can help: Donate plasma
Kombination Keywords plasma donate | behring help | covid that | alliance location | covig have | from health | trial people | patients this | more serious | learn with |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering serious health cons Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering seri
Text Inhalt Text aus URL
Log Metriken 446053
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Julie Kim | Bill Mezzanotte | Melinda Gates | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine How you can help: Donate plasma
Kombination Keywords plasma donate | behring help | covid that | alliance location | covig have | from health | trial people | patients this | more serious | learn with |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering serious health cons Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering seri
Text Inhalt Text aus URL
Log Metriken 446053
erkannte Namen Julie Kim | Bill Mezzanotte | Melinda Gates | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine How you can help: Donate plasma
Kombination Keywords plasma donate | behring help | covid that | alliance location | covig have | from health | trial people | patients this | more serious | learn with |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering serious health cons Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering seri
Text Inhalt Text aus URL
Log Metriken 446053
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Julie Kim | Bill Mezzanotte | Melinda Gates | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine How you can help: Donate plasma
Kombination Keywords plasma donate | behring location | covid find | alliance this | from have | covig that | trial serious | more people | learn with | patients health |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering serious health cons Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering seri
Text Inhalt Text aus URL
Log Metriken 446053
erkannte Namen Julie Kim | Bill Mezzanotte | Melinda Gates | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 7
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine How you can help: Donate plasma
Kombination Keywords plasma donate | behring location | covid find | alliance this | from have | covig that | trial serious | more people | learn with | patients health |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering serious health cons Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanese Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 " If the trial proves successful, this therapy could bring new hope to those suffering seri
Text Inhalt Text aus URL
Log Metriken 446053
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Julie Kim | Bill Mezzanotte | Luc Rapin | Melinda Gates | Sandra Ruckstuhl | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 9
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Erster Patient für die NIH Phase 3-Studie zur Evaluierung potenzieller Hyperimmun-Therapie gegen COVID-19 registriert Berner Beitrag
Kombination Keywords plasma karrieren | covid finden | behring produkt | covig news | studie phase | allianz denen | patienten unsere | mehr krankheiten | erfahren standort | therapie bern |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanische Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 « Wenn sich die Studie als erfolgreich erweist, könnte diese Therapie denen neue Hoffnung geben, die auf Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanische Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 « Wenn sich die Studie als erfolgreich erweist, könnte diese Therapie denen neue Hoffnung
Text Inhalt Text aus URL
Log Metriken 445556
erkannte Namen Julie Kim | Bill Mezzanotte | Luc Rapin | Melinda Gates | Sandra Ruckstuhl | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 9
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Erster Patient für die NIH Phase 3-Studie zur Evaluierung potenzieller Hyperimmun-Therapie gegen COVID-19 registriert Berner Beitrag
Kombination Keywords plasma karrieren | covid finden | behring produkt | covig news | studie phase | allianz denen | patienten unsere | mehr krankheiten | erfahren standort | therapie bern |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanische Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 « Wenn sich die Studie als erfolgreich erweist, könnte diese Therapie denen neue Hoffnung geben, die auf Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanische Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 « Wenn sich die Studie als erfolgreich erweist, könnte diese Therapie denen neue Hoffnung
Text Inhalt Text aus URL
Log Metriken 445556
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Julie Kim | Bill Mezzanotte | Luc Rapin | Melinda Gates | Sandra Ruckstuhl | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 9
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Erster Patient für die NIH Phase 3-Studie zur Evaluierung potenzieller Hyperimmun-Therapie gegen COVID-19 registriert Berner Beitrag
Kombination Keywords plasma karrieren | covid finden | behring produkt | covig news | studie phase | allianz denen | patienten unsere | mehr krankheiten | erfahren standort | therapie bern |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanische Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 « Wenn sich die Studie als erfolgreich erweist, könnte diese Therapie denen neue Hoffnung geben, die auf Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanische Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 « Wenn sich die Studie als erfolgreich erweist, könnte diese Therapie denen neue Hoffnung
Text Inhalt Text aus URL
Log Metriken 445556
erkannte Namen Julie Kim | Bill Mezzanotte | Luc Rapin | Melinda Gates | Sandra Ruckstuhl | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 9
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Erster Patient für die NIH Phase 3-Studie zur Evaluierung potenzieller Hyperimmun-Therapie gegen COVID-19 registriert Berner Beitrag
Kombination Keywords plasma karrieren | covid finden | behring produkt | covig news | studie phase | allianz denen | patienten unsere | mehr krankheiten | erfahren standort | therapie bern |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanische Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 « Wenn sich die Studie als erfolgreich erweist, könnte diese Therapie denen neue Hoffnung geben, die auf Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanische Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 « Wenn sich die Studie als erfolgreich erweist, könnte diese Therapie denen neue Hoffnung
Text Inhalt Text aus URL
Log Metriken 445556
www.cslbehring.ch
Datum der Indexierung
erkannte Namen Julie Kim | Bill Mezzanotte | Luc Rapin | Melinda Gates | Sandra Ruckstuhl | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 9
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Erster Patient für die NIH Phase 3-Studie zur Evaluierung potenzieller Hyperimmun-Therapie gegen COVID-19 registriert Berner Beitrag
Kombination Keywords plasma karrieren | covid finden | behring produkt | covig news | studie phase | allianz denen | patienten unsere | mehr krankheiten | erfahren standort | therapie bern |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanische Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 « Wenn sich die Studie als erfolgreich erweist, könnte diese Therapie denen neue Hoffnung geben, die auf Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanische Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 « Wenn sich die Studie als erfolgreich erweist, könnte diese Therapie denen neue Hoffnung
Text Inhalt Text aus URL
Log Metriken 445556
erkannte Namen Julie Kim | Bill Mezzanotte | Luc Rapin | Melinda Gates | Sandra Ruckstuhl | Greg Healy | Oswald Posaune | Daniel Bolz | Karin Holzinstrumente |
weitere Namen in www.cslbehring.ch 9
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Erster Patient für die NIH Phase 3-Studie zur Evaluierung potenzieller Hyperimmun-Therapie gegen COVID-19 registriert Berner Beitrag
Kombination Keywords plasma karrieren | covid finden | behring produkt | covig news | studie phase | allianz denen | patienten unsere | mehr krankheiten | erfahren standort | therapie bern |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Kate Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanische Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 « Wenn sich die Studie als erfolgreich erweist, könnte diese Therapie denen neue Hoffnung geben, die auf Niazi-Sai, kate.niazi-sai@takeda.com ; +1 617 335 0023 Japanische Media: Kazumi Kobayashi, kazumi.kobayashi@takeda.com ; +81 (0) 3-3278-2095 « Wenn sich die Studie als erfolgreich erweist, könnte diese Therapie denen neue Hoffnung
Text Inhalt Text aus URL
Log Metriken 445556